OBJECTIVE: To summarize the current knowledge of the mechanisms leading to rebleeding and the prevention of rebleeding after subarachnoid hemorrhage (SAH). METHODS: A literature search was performed to investigate factors associated with rebleeding after SAH. RESULTS: The review of the literature revealed that rebleeding is a complex and multifactorial event involving hemostasis, pathophysiologic, and anatomic factors. Administration of antifibrinolytics has been shown to have a dramatic effect on the rebleeding rate, so changes in coagulation and fibrinolysis must be involved in rebleeding. CONCLUSIONS: Further studies are warranted before the exact mechanisms leading to rebleeding are established and the optimal preventive measures are made available. At the present time, antifibrinolytic therapy remains the only realistic protective measure during the initial 6 hours after SAH during which the rebleeding rate is highest.
OBJECTIVE: To summarize the current knowledge of the mechanisms leading to rebleeding and the prevention of rebleeding after subarachnoid hemorrhage (SAH). METHODS: A literature search was performed to investigate factors associated with rebleeding after SAH. RESULTS: The review of the literature revealed that rebleeding is a complex and multifactorial event involving hemostasis, pathophysiologic, and anatomic factors. Administration of antifibrinolytics has been shown to have a dramatic effect on the rebleeding rate, so changes in coagulation and fibrinolysis must be involved in rebleeding. CONCLUSIONS: Further studies are warranted before the exact mechanisms leading to rebleeding are established and the optimal preventive measures are made available. At the present time, antifibrinolytic therapy remains the only realistic protective measure during the initial 6 hours after SAH during which the rebleeding rate is highest.
Authors: C J Reuß; M Bernhard; C Beynon; S Hofer; C Jungk; D Michalski; M A Weigand; T Brenner Journal: Anaesthesist Date: 2016-07 Impact factor: 1.041
Authors: F D'Argento; A Pedicelli; C Ciardi; E Leone; M Scarabello; A Infante; A Alexandre; E Lozupone; I Valente; C Colosimo Journal: Radiol Med Date: 2020-09-09 Impact factor: 3.469
Authors: Oliver Richards; Kirsten J Cromie; Christopher Akhunbay-Fudge; Neeraj Kalra; Richard G Feltbower; Paul Chumas; Ian A Anderson Journal: Acta Neurochir (Wien) Date: 2022-01-18 Impact factor: 2.216
Authors: William C Johnson; Nicolas A Morton-Gonzaba; John V Lacci; Daniel Godoy; Alireza Mirahmadizadeh; Ali Seifi Journal: Neurocrit Care Date: 2019-04 Impact factor: 3.210
Authors: Fawaz Al-Mufti; Stephan A Mayer; Gurmeen Kaur; Daniel Bassily; Boyi Li; Matthew L Holstein; Jood Ani; Nicole E Matluck; Haris Kamal; Rolla Nuoman; Christian A Bowers; Faizan S Ali; Hussein Al-Shammari; Mohammad El-Ghanem; Chirag Gandhi; Krishna Amuluru Journal: Neuroradiol J Date: 2021-09-03
Authors: Dannys Rivero Rodríguez; Claudio Scherle Matamoros; Leda Fernández Cúe; Jose Luis Miranda Hernández; Yanelis Pernas Sánchez; Jesús Pérez Nellar Journal: Neurol Res Int Date: 2015-02-05
Authors: Sean N Neifert; Emily K Chapman; Michael L Martini; William H Shuman; Alexander J Schupper; Eric K Oermann; J Mocco; R Loch Macdonald Journal: Transl Stroke Res Date: 2020-10-19 Impact factor: 6.829